Literature DB >> 2569478

Hemopoietic origin of factor XIII A subunits in platelets, monocytes, and plasma. Evidence from bone marrow transplantation studies.

M C Poon1, J A Russell, S Low, G D Sinclair, A R Jones, W Blahey, B A Ruether, D I Hoar.   

Abstract

Factor XIII A subunit (FXIIIA) is found in plasma, platelets, and monocytes. The hemopoietic contributions to FXIIIA in these components were studied in patients transplanted with marrows from donors with different FXIIIA phenotypes. In three patients with successful engraftment (by DNA genotyping, red cell phenotyping, and cytogenetic studies) platelet and monocyte FXIIIA changed to donor phenotypes with hematologic recovery. Thus, FXIIIA in platelets and monocytes is synthesized de novo and/or from their progenitor cells. Plasma FXIIIA phenotype change after transplantation was more complex. Patient I changed from phenotype 1-1 (one electrophoretically fast band) to 1-2 (three bands) in 115 d; patients 2 and 3 did not change completely from phenotype 1-2 to 1-1 in up to 458 d, but did show enrichment of the fastest band. Thus, while there is a definite contribution of donor hemopoiesis to plasma FXIIIA, another source of recipient FXIIIA appears to be present to delay or prevent the phenotype change.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569478      PMCID: PMC329720          DOI: 10.1172/JCI114237

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  PLASMA FIBRIN STABILIZING FACTOR ACTIVITY IN VARIOUS DISEASES.

Authors:  M NUSSBAUM; B S MORSE
Journal:  Blood       Date:  1964-05       Impact factor: 22.113

2.  Retention of platelet fibrin stabilizing factor during the platelet release reaction and clot retraction.

Authors:  J H Joist; S Niewiarowski
Journal:  Thromb Diath Haemorrh       Date:  1973-06-28

3.  Factors affecting factor XIII assay by dansyl cadaverine incorporation.

Authors:  M J Sheltawy; K Miloszewski; M S Losowsky
Journal:  Thromb Diath Haemorrh       Date:  1972-12-31

4.  Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leucocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility.

Authors:  A Dvilansky; A F Britten; A G Loewy
Journal:  Br J Haematol       Date:  1970-04       Impact factor: 6.998

5.  Evidence concerning the origin of liver macrophages.

Authors:  L S Kelly; E L Dobson
Journal:  Br J Exp Pathol       Date:  1971-02

6.  Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures.

Authors:  S I Chung; M S Lewis; J E Folk
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

7.  Comparative studies on tissue transglutaminase and factor XIII.

Authors:  S I Chung
Journal:  Ann N Y Acad Sci       Date:  1972-12-08       Impact factor: 5.691

8.  Comparative studies on the fibrin-stabilizing factors from human plasma, platelets and placentas.

Authors:  H Bohn
Journal:  Ann N Y Acad Sci       Date:  1972-12-08       Impact factor: 5.691

9.  Demonstration of factor XIII in human megakaryocytes by a fluorescent antibody technique.

Authors:  T H Kiesselbach; R H Wagner
Journal:  Ann N Y Acad Sci       Date:  1972-12-08       Impact factor: 5.691

10.  Immunologic studies of proteins associated with subcellular fractions of normal human platelets.

Authors:  R L Nachman; A J Marcus; D Zucker-Franklin
Journal:  J Lab Clin Med       Date:  1967-04
View more
  12 in total

1.  Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5' end of exon III.

Authors:  T Kamura; T Okamura; M Murakawa; H Tsuda; T Teshima; T Shibuya; M Harada; Y Niho
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue transglutaminase.

Authors:  M Raghunath; B Höpfner; D Aeschlimann; U Lüthi; M Meuli; S Altermatt; R Gobet; L Bruckner-Tuderman; B Steinmann
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

3.  Immunohistochemical detection of factor XIIIa and factor XIIIs in synovial membranes of patients with rheumatoid arthritis or osteoarthritis.

Authors:  A Plenz; P Fritz; G König; W Laschner; J G Saal
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

4.  Cellular Factor XIIIA Transglutaminase Localizes in Caveolae and Regulates Caveolin-1 Phosphorylation, Homo-oligomerization and c-Src Signaling in Osteoblasts.

Authors:  Shuai Wang; Mari T Kaartinen
Journal:  J Histochem Cytochem       Date:  2015-07-31       Impact factor: 2.479

5.  Characterization of coagulation factor synthesis in nine human primary cell types.

Authors:  Monireh Dashty; Vishtaseb Akbarkhanzadeh; Clark J Zeebregts; C Arnold Spek; Eric J Sijbrands; Maikel P Peppelenbosch; Farhad Rezaee
Journal:  Sci Rep       Date:  2012-11-09       Impact factor: 4.379

6.  Cre/lox Studies Identify Resident Macrophages as the Major Source of Circulating Coagulation Factor XIII-A.

Authors:  Cora M L Beckers; Kingsley R Simpson; Kathryn J Griffin; Jane M Brown; Lih T Cheah; Kerrie A Smith; Jean Vacher; Paul A Cordell; Mark T Kearney; Peter J Grant; Richard J Pease
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-08       Impact factor: 8.311

7.  Monocytes Expose Factor XIII-A and Stabilize Thrombi against Fibrinolytic Degradation.

Authors:  Fahad S M Alshehri; Claire S Whyte; Ahmet Tuncay; Maria-Louise Williams; Heather M Wilson; Nicola J Mutch
Journal:  Int J Mol Sci       Date:  2021-06-19       Impact factor: 5.923

8.  A journey upstream: Fluctuating platelet-specific genes in cell-free plasma as proof-of-concept for using ribonucleic acid sequencing to improve understanding of postinjury platelet biology.

Authors:  Lucy Zumwinkle Kornblith; Cedric M V Bainton; Alexander T Fields; Zachary A Matthay; Nina T Magid; Brenda Nunez-Garcia; Arun Prakash; Philip A Kurien; Rachael A Callcut; Mitchell J Cohen; Roland J Bainton
Journal:  J Trauma Acute Care Surg       Date:  2020-06       Impact factor: 3.697

9.  Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet.

Authors:  Vamsee D Myneni; Aisha Mousa; Mari T Kaartinen
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

Review 10.  Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment.

Authors:  Lilla Paragh; Daniel Törőcsik
Journal:  Biomed Res Int       Date:  2017-08-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.